@article{TCR16310,
author = {Nicola Normanno},
title = {Monitoring response to therapy by testing circulating tumor DNA in urine},
journal = {Translational Cancer Research},
volume = {6},
number = {Suppl 7},
year = {2017},
keywords = {},
abstract = {Husain and co-workers assessed the levels of epidermal growth factor receptor (EGFR) mutations in urine samples of advanced non-small cell lung cancer (NSCLC) patients receiving the third generation EGFR tyrosine kinase inhibitor (TKI) osimertinib (1).},
issn = {2219-6803}, url = {https://tcr.amegroups.org/article/view/16310}
}